1,440
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Differences in neonatal adverse outcomes among women with gestational diabetes mellitus managed by diet or medication: a propensity score matched analysis of a population-based sample

ORCID Icon, , ORCID Icon, , , , & ORCID Icon show all
Article: 2250005 | Received 28 Nov 2022, Accepted 14 Aug 2023, Published online: 23 Aug 2023

References

  • American Diabetes Association Professional Practice Committee; 2. Classification and diagnosis of diabetes: standards of medical care in diabetes—2022. Diabetes Care. 2022;45(Supplement_1):1–7. doi:10.2337/dc22-S002.
  • Saccone G, Khalifeh A, Al-Kouatly HB, et al. Screening for gestational diabetes mellitus: one step versus two step approach. A meta-analysis of randomized trials. J Matern Fetal Neonatal Med. 2020;33(9):1616–1624. doi:10.1080/14767058.2018.1519543.
  • Poston L, Caleyachetty R, Cnattingius S, et al. Preconceptional and maternal obesity: epidemiology and health consequences. Lancet Diabetes Endocrinol. 2016;4(12):1025–1036. doi:10.1016/S2213-8587(16)30217-0.
  • Mnatzaganian G, Woodward M, McIntyre HD, et al. Trends in percentages of gestational diabetes mellitus attributable to overweight, obesity, and morbid obesity in regional Victoria: an eight-year population-based panel study. BMC Pregnancy Childbirth. 2022;22(1):95. doi:10.1186/s12884-022-04420-9.
  • International Association Of D, Pregnancy Study Groups Consensus P, Metzger BE, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010;33:676–682.
  • Metzger BE, Lowe LP, Dyer AR, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008;358(19):1991–2002. doi:10.1056/NEJMoa0707943.
  • Lowe WL, Jr., Scholtens DM, Lowe LP, et al. Association of gestational diabetes with maternal disorders of glucose metabolism and childhood adiposity. JAMA. 2018;320(10):1005–1016. doi:10.1001/jama.2018.11628.
  • Blotsky AL, Rahme E, Dahhou M, et al. Gestational diabetes associated with incident diabetes in childhood and youth: a retrospective cohort study. CMAJ. 2019;191(15):E410–E417. doi:10.1503/cmaj.181001.
  • Caissutti C, Saccone G, Ciardulli A, et al. Very tight vs. tight control: what should be the criteria for pharmacologic therapy dose adjustment in diabetes in pregnancy? Evidence from randomized controlled trials. Acta Obstet Gynecol Scand. 2018;97(3):235–247. doi:10.1111/aogs.13257.
  • Hartling L, Dryden DM, Guthrie A, et al. Benefits and harms of treating gestational diabetes mellitus: a systematic review and meta-analysis for the U.S. Preventive services task force and the national institutes of health office of medical applications of research. Ann Intern Med. 2013;159(2):123–129. doi:10.7326/0003-4819-159-2-201307160-00661.
  • American Diabetes A. 14. Management of diabetes in pregnancy: standards of medical care in diabetes-2019. Diabetes Care. 2019;42(Suppl 1):S165–S72.
  • American Diabetes A. (12) Management of diabetes in pregnancy. Diabetes Care. 2015;38 (Supplement 1):S77–S9.
  • Yamamoto JM, Kellett JE, Balsells M, et al. Gestational diabetes mellitus and diet: a systematic review and meta-analysis of randomized controlled trials examining the impact of modified dietary interventions on maternal glucose control and neonatal birth weight. Diabetes Care. 2018;41(7):1346–1361. doi:10.2337/dc18-0102.
  • Caissutti C, Saccone G, Khalifeh A, et al. Which criteria should be used for starting pharmacologic therapy for management of gestational diabetes in pregnancy? Evidence from randomized controlled trials. J Matern Fetal Neonatal Med. 2019;32(17):2905–2914. doi:10.1080/14767058.2018.1449203.
  • Koning SH, Hoogenberg K, Scheuneman KA, et al. Neonatal and obstetric outcomes in diet- and insulin-treated women with gestational diabetes mellitus: a retrospective study. BMC Endocr Disord. 2016;16(1):52. doi:10.1186/s12902-016-0136-4.
  • Benhalima K, Robyns K, Van Crombrugge P, et al. Differences in pregnancy outcomes and characteristics between insulin- and diet-treated women with gestational diabetes. BMC Pregnancy Childbirth. 2015;15:271. doi:10.1186/s12884-015-0706-x.
  • Bashir M, Aboulfotouh M, Dabbous Z, et al. Metformin-treated-GDM has lower risk of macrosomia compared to diet-treated GDM- a retrospective cohort study. J Matern Fetal Neonatal Med. 2020;33(14):2366–2371. doi:10.1080/14767058.2018.1550480.
  • Mnatzaganian G, Davidson DC, Hiller JE, et al. Propensity score matching and randomization. J Clin Epidemiol. 2015;68(7):760–768. doi:10.1016/j.jclinepi.2015.01.002.
  • Rosenbaum PR, Rubin DB. The Central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70(1):41–55. doi:10.1093/biomet/70.1.41.
  • Ward MC, Agarwal A, Bish M, et al. Trends in obesity and impact on obstetric outcomes in a regional hospital in Victoria, Australia. Aust N Z J Obstet Gynaecol. 2020;60(2):204–211. doi:10.1111/ajo.13035.
  • Australian Bureau of Statistics. SEIFA: socio‐Economic Indexes for Areas. 2022. Available from: https://www.abs.gov.au/websitedbs/censushome.nsf/home/seifa.
  • Dobbins TA, Sullivan EA, Roberts CL, et al. Australian national birthweight percentiles by sex and gestational age, 1998–2007. Med J Aust. 2012;197(5):291–294. Erratum in: med J Aust. 2013;198:189. doi:10.5694/mja11.11331.
  • Martin FIR. The diagnosis of gestational diabetes. Med J Aust. 1991;155(2):112.
  • WHO. World Health Organization. Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy. Geneva: WHO Press; 2013.
  • Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG). Excellence in Women’s Health. 2020. https://ranzcog.edu.au.
  • Department of Health. Clinical practice guidelines: pregnancy care. 2020. Canberra: Australian Government Department of Health.
  • Hoffman L, Nolan C, Wilson JD, et al. Gestational diabetes mellitus – management guidelines. The australasian diabetes in pregnancy ­society. Med J Aust. 1998;169(2):93–97. doi:10.5694/j.1326-5377.1998.tb140192.x.
  • Langer O, Rodriguez DA, Xenakis EM, et al. Intensified versus conventional management of gestational diabetes. Am J Obstet Gynecol. 1994;170(4):1036–1046. discussion 46-7. doi:10.1016/s0002-9378(94)70097-4.
  • McCance DR. Pregnancy and diabetes. Best Pract Res Clin Endocrinol Metab. 2011;25(6):945–958. doi:10.1016/j.beem.2011.07.009.
  • Hillier TA, Vesco KK, Pedula KL, et al. Screening for gestational diabetes mellitus: a systematic review for the U.S. Preventive services task force. Ann Intern Med. 2008;148(10):766–775. doi:10.7326/0003-4819-148-10-200805200-00009.
  • Mendez-Figueroa H, Schuster M, Maggio L, et al. Gestational diabetes mellitus and frequency of blood glucose monitoring: a randomized controlled trial. Obstet Gynecol. 2017;130(1):163–170. doi:10.1097/AOG.0000000000002101.
  • Catalano PM, McIntyre HD, Cruickshank JK, et al. The hyperglycemia and adverse pregnancy outcome study. Associations of GDM and obesity with pregnancy outcomes. Diabetes Care. 2012;35(4):780–786. doi:10.2337/dc11-1790.
  • Brown J, Grzeskowiak L, Williamson K, et al. Insulin for the treatment of women with gestational diabetes. Cochrane Database Syst Rev. 2017;11(11):CD012037. doi:10.1002/14651858.CD012037.pub2.
  • Oostdam N, van Poppel MN, Wouters MG, et al. No effect of the FitFor2 exercise programme on blood glucose, insulin sensitivity, and birthweight in pregnant women who were overweight and at risk for gestational diabetes: results of a randomised controlled trial. BJOG. 2012;119(9):1098–1107. doi:10.1111/j.1471-0528.2012.03366.x.
  • Egan AM, Simmons D. Lessons learned from lifestyle prevention trials in gestational diabetes mellitus. Diabet Med. 2019;36(2):142–150. doi:10.1111/dme.13772.
  • Moss JR, Crowther CA, Hiller JE, et al. Costs and consequences of treatment for mild gestational diabetes mellitus - evaluation from the ACHOIS randomised trial. BMC Pregnancy Childbirth. 2007;7:27. doi:10.1186/1471-2393-7-27.
  • Crowther CA, Hiller JE, Moss JR, et al. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med. 2005;352(24):2477–2486. doi:10.1056/NEJMoa042973.
  • Kapur K, Kapur A, Hod M. Nutrition management of gestational diabetes mellitus. Ann Nutr Metab. 2021;76(suppl 3):1–13. doi:10.1159/000509900.
  • Simeonova-Krstevska S, Bogoev M, Bogoeva K, et al. Maternal and neonatal outcomes in pregnant women with gestational diabetes mellitus treated with diet, metformin or insulin. Open Access Maced J Med Sci. 2018;6(5):803–807. doi:10.3889/oamjms.2018.200.
  • Brawerman GM, Dolinsky VW. Therapies for gestational diabetes and their implications for maternal and offspring health: evidence from human and animal studies. Pharmacol Res. Apr. 2018;130:52–73. doi:10.1016/j.phrs.2018.02.002.
  • Langer O. Oral antidiabetic drugs in pregnancy: the other alternative. Diabetes Spectrum. 2007;20(2):101–105. doi:10.2337/diaspect.20.2.101.
  • Hyer S, Balani J, Shehata H. Metformin in pregnancy: mechanisms and clinical applications. Int J Mol Sci. 2018;19:1954. doi:10.3390/ijms19071954.
  • Rowan JA, Hague WM, Gao W, et al. Metformin versus insulin for the treatment of gestational diabetes. N Engl J Med. 2008;358(19):2003–2015. doi:10.1056/NEJMoa0707193.